PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)
Year: 2012
Type: conference-abstract
Source: Value in Health
Authors: F. Zhang, R. Hiscock, J. Curtis
Institutions: Celgene (United States), University of Alabama at Birmingham
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2000345837
